Fortress Biotech (NASDAQ:FBIO) Posts Earnings Results, Beats Estimates By $0.12 EPS
Market Beat·
- Fortress Biotech reported a quarterly EPS of ($0.08), beating consensus estimates of ($0.20) by $0.12 alongside revenue of $18.72 million.
- The biopharmaceutical company's stock traded up $0.23 to $2.98 following the earnings announcement, with institutional investors and hedge funds holding 96.51% of the shares.
- Fortress Biotech focuses on acquiring, developing, and commercializing novel pharmaceutical and biotechnology products through a network of majority-owned subsidiaries.